KIF11 is a potential prognostic biomarker and therapeutic target for adrenocortical carcinoma.

Publication Year: 2023

DOI:
10.21037/tau-22-706

PMCID:
PMC10170266

PMID:
37181234

Journal Information

Full Title: Transl Androl Urol

Abbreviation: Transl Androl Urol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Urology & Nephrology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-22-706/coif). XC reports the funding from Xiangya Clinical Data System of Central South University. The other authors have no conflicts of interest to declare."

Evidence found in paper:

"Funding: This work was supported by grants from Xiangya Clinical Data System of Central South University (to Xiang Chen)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025